Boston Trust Walden Corp Lowers Stake in CorVel Corp. $CRVL

Boston Trust Walden Corp lessened its holdings in CorVel Corp. (NASDAQ:CRVL) by 1.5% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 529,082 shares of the business services provider’s stock after selling 7,792 shares during the quarter. Boston Trust Walden Corp owned about 1.03% of CorVel worth $40,962,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in the business. Norges Bank purchased a new stake in shares of CorVel in the 2nd quarter worth approximately $34,418,000. Thrivent Financial for Lutherans boosted its holdings in CorVel by 187.9% in the second quarter. Thrivent Financial for Lutherans now owns 400,003 shares of the business services provider’s stock worth $41,112,000 after acquiring an additional 261,049 shares in the last quarter. Assenagon Asset Management S.A. grew its stake in shares of CorVel by 720.9% in the second quarter. Assenagon Asset Management S.A. now owns 102,478 shares of the business services provider’s stock worth $10,533,000 after acquiring an additional 89,994 shares during the last quarter. Cubist Systematic Strategies LLC increased its holdings in shares of CorVel by 249.0% during the second quarter. Cubist Systematic Strategies LLC now owns 117,395 shares of the business services provider’s stock valued at $12,066,000 after acquiring an additional 83,757 shares in the last quarter. Finally, Jones Financial Companies Lllp raised its position in shares of CorVel by 23,616.8% in the 1st quarter. Jones Financial Companies Lllp now owns 78,977 shares of the business services provider’s stock worth $8,843,000 after purchasing an additional 78,644 shares during the last quarter. 51.36% of the stock is currently owned by hedge funds and other institutional investors.

CorVel Stock Performance

CRVL opened at $68.60 on Tuesday. The company’s 50-day simple moving average is $72.44 and its two-hundred day simple moving average is $82.95. The stock has a market capitalization of $3.52 billion, a P/E ratio of 33.79 and a beta of 1.09. CorVel Corp. has a 52-week low of $66.49 and a 52-week high of $128.61.

CorVel (NASDAQ:CRVL) last announced its quarterly earnings results on Tuesday, November 4th. The business services provider reported $0.54 EPS for the quarter. The firm had revenue of $239.64 million during the quarter. CorVel had a net margin of 11.28% and a return on equity of 31.72%.

Wall Street Analyst Weigh In

Several brokerages recently commented on CRVL. Weiss Ratings reissued a “hold (c)” rating on shares of CorVel in a research report on Tuesday, October 14th. Wall Street Zen cut shares of CorVel from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, CorVel has a consensus rating of “Hold”.

Insider Buying and Selling at CorVel

In other news, EVP Mark E. Bertels sold 1,200 shares of the firm’s stock in a transaction on Wednesday, November 19th. The stock was sold at an average price of $72.35, for a total value of $86,820.00. Following the transaction, the executive vice president directly owned 2,594 shares in the company, valued at $187,675.90. This trade represents a 31.63% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director R Judd Jessup sold 7,076 shares of the company’s stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $76.94, for a total value of $544,427.44. Following the sale, the director owned 115,045 shares of the company’s stock, valued at approximately $8,851,562.30. This trade represents a 5.79% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 11,733 shares of company stock worth $894,686 over the last three months. Insiders own 44.56% of the company’s stock.

CorVel Profile

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).